Interestingly, we observed that the highly expressed Sox7 was associated with the reduced expressions of CyclinD1 and FGF9 in these overexpressed β-catenin endometrial cancer samples, suggesting Sox7 has a negative regulatory role in suppressing Wnt/β-catenin signaling activity in endometrial cancer. Here, SOX7 is linked to endometrial cancer.